Market revenue in 2023 | USD 9,031.4 million |
Market revenue in 2030 | USD 22,323.5 million |
Growth rate | 13.8% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Liquid Oral |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Liquid Oral, Powder In Sachet / Jar, Gummies, Energy Bars, Other suitable forms (Diskettes, etc.) |
Key market players worldwide | Ashland Inc, Glanbia PLC, Herbalife Ltd, Menadiona, Twinlab Consolidated Holdings Inc, Nutrivo, Gemini Pharmaceuticals, Rain Nutrience |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nutraceutical contract manufacturing services market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 25.27% in 2023. Horizon Databook has segmented the South Korea nutraceutical contract manufacturing services market based on tablets, capsules, liquid oral, powder in sachet / jar, gummies, energy bars, other suitable forms (diskettes, etc.) covering the revenue growth of each sub-segment from 2018 to 2030.
Food and health foods in South Korea have their own language and classification system. The Korean Health/Functional Food Act, a new regulatory framework for ensuring the effectiveness, safety, and labeling of Health Functional Foods (HFFs), was enacted in January 2004.
The act mandates that HFFs be sold in dose-restricted forms, such as tablets, capsules, pills, and liquids. The government body overseeing the safety of food, medications, medical devices, and cosmetics in South Korea is the Ministry of Food and Drug Safety (MFDS), known as the Korea Food and Drug Administration (KFDA).
Every product introduced on the market needs to be reported to the MFDS. The MFDS must first approve non-listed ingredients after reviewing the product’s functionality and safety. The exclusive power to grant premarket approval lies with MFDS.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea nutraceutical contract manufacturing services market , including forecasts for subscribers. This country databook contains high-level insights into South Korea nutraceutical contract manufacturing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account